Free cookie consent management tool by TermsFeed Policy Generator Industry sponsored sessions | 19th European AIDS Conference

Industry sponsored sessions

Discovering Healthcare Advancements: Sponsored Sessions Guide

  • Esteemed professionals in the field will analyze recent trials and discoveries that will mold the future of clinical practice.
  • Stay informed about the most recent data concerning HIV & co-infections progress and solutions.
Wednesday, 18 October

12:00 – 13:00,  room POLONEZ

Industry Sponsored Session – Virology Education

The Devil Wears GP120

Chair: Miłosz Parczewski (Poland)

Welcome by the Symposium Chair

  • Miłosz Parczewski (Poland)

12:00 - 12:05

The Role of GP120 in HIV Pathogenesis and Its Interactions with the Immune System

  • Aurelio Orta-Resendiz (France)

12:05 - 12:20

Clinical Data from the GP120 Inhibitor Temsavir and Its Potential Relevance to Immune Reconstitution and HIV
Associated Inflammation

  • Georg Behrens (Germany)

12:20 - 12:35

Future Study of GP120 Inhibitors as Potential Immunomodulators in Clinical Care

  • Clíona Ní Cheallaigh (Ireland)

12:35 - 12:50

Discussion - Live Q&A

12:50 - 13:00

Closure of the Symposium

  • Miłosz Parczewski (Poland)
13:00

15:00 – 16:30,  room POLONEZ

Industry Sponsored Session – PeerVoice

Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey

Chair: Sharon Walmsley (Canada)

Welcome and Introduction

  • Sharon Walmsley (Canada)

15:00 - 15:05

Living a Full Live with HIV

  • Susan Cole (UK)
15:05 – 15:12

Initiating ART at Diagnosis: When and With What?

  • Sharon Walmsley (Canada)
  • Justyna Kowalska (Poland)
  • Karoline Aebi-Popp (Switzerland)
  • Susan Cole (UK)
15:12 – 15:29

ART and Pregnancy: How Do We Ensure ‘Safe’ Management of Mother and Baby?

  • Sharon Walmsley (Canada)
  • Justyna Kowalska (Poland)
  • Karoline Aebi-Popp (Switzerland)
  • Susan Cole (UK)

15:29 – 15:46

When Viral Suppression is Achieved: What Now?

  • Sharon Walmsley (Canada)
  • Justyna Kowalska (Poland)
  • Karoline Aebi-Popp (Switzerland)
  • Susan Cole (UK)
15:46 – 16:03

Managing Age-Related Changes Alongside Maintaining Viral Suppression: Menopause and More!

  • Sharon Walmsley (Canada)
  • Justyna Kowalska (Poland)
  • Karoline Aebi-Popp (Switzerland)
  • Susan Cole (UK)
16:03 - 16:20
"Ask the Faculty” and Take-Home Messages 16:20 - 16:30

16:30 - 17:30,  room MAZUREK

Industry Sponsored Session – ViiV Healthcare

The Power of Voice: Focusing on Health-Related Quality of Life in People Living with HIV

Chair: Justyna Kowalska (Poland), Christine Katlama (France)

Welcome and introduction

  • Justyna Kowalska (Poland)
16:30 – 16:32

HIV + healthy: What does it really mean?

  • Ana Milinkovic (UK)

16:32 - 16:47

Individual perspectives on individualising HIV care

  • Miłosz Parczewski (Poland)
  • Giovanni Guaraldi (Italy)
16:47 – 17:12

Panel discussion and Q&A

17:12 – 17:27

Conclusions and close

  • Christine Katlama (France)
17:27 – 17:30

This ViiV Healthcare-sponsored promotional symposium is intended for prescribing healthcare professionals only. According to local regulations in Poland, this symposium should not be attended by non-prescribing healthcare professionals. Date of approval: September 2023 NP-GBL-HVX-WCNT-230033

16:30 - 17:30,  room ETIUDA

Industry Sponsored Session – Bavarian Nordic

What is the path to mpox elimination and control?

Chair: Magdalena Ankiersztejn-Bartczak (Poland)

Introduction by symposium chair

  • Magdalena Ankiersztejn-Bartczak (Poland)
16:30 - 16:40

Global strategic framework for mpox elimination – integration with HIV & STI programs

  • Rosamund Lewis (Switzerland)
16:40 - 16:55

Mobilization & Advocacy: The Queer Community & The Mpox Response

  • Alex Garner (USA)
16:55 - 17:10
Q&A 17:10 - 17:30
Thursday, 19 October

12:15 - 13:45, room POLONEZ

Industry Sponsored Session – ViiV Healthcare

The power of choice: Taking an individualised approach to HIV care

Chair: Nneka Nwokolo (UK), Georg Behrens (Germany)

Welcome and introduction to individualised care

  • Nneka Nwokolo (UK)
  • Georg Behrens (Germany)
12:15 – 12:30

The power of choice: Recent evidence and experience of two-drug regimens

  • Federico García (Spain)
  • Miguel Abreu (Portugal)
12:30 – 13:05

The power of choice: Unlocking long-acting treatment options in HIV care

  • Juan Ambrosioni (Spain)
  • Sebastian Noe (Germany)
  • Nicola Gianotti (Italy)
13:05 – 13:40

Conclusions and close

  • Nneka Nwokolo (UK)
  • Georg Behrens (Germany)
13:40 – 13:45

This ViiV Healthcare-sponsored promotional symposium is intended for prescribing healthcare professionals only. According to local regulations in Poland, this symposium should not be attended by non-prescribing healthcare professionals. Date of approval: September 2023 PM-GBL-HVX-BRFS-230003

16:00 - 17:00, room POLONEZ

Industry Sponsored Session – MSD

Current and key topics in HIV management - A collaborative discussion

Chair: Miłosz Parczewski (Poland)

Welcome and introduction

  • Miłosz Parczewski (Poland)
16:00 – 16:10

Should cardiometabolic considerations play a role in HIV treatment decision?

  • Miłosz Parczewski (Poland)
16:10 – 16:25

Individualization of treatment: Does one size fit all?

  • Kees Brinkman (The Netherlands)
16:25 – 16:40

When would a next-generation NNRTI be the best option?

  • Tristan Barber (UK)
16:40 – 16:55

Closing remarks

  • Miłosz Parczewski (Poland)
16:55 – 17:00

This session is for prescribers only.

18:45 - 19:45, room POLONEZ

Industry Sponsored Session – Gilead

Treatment Selection for Long-Term Success: A Question of Empowerment 

Chair: David Malebranche (USA)

Welcome and introduction

  • David Malebranche (USA)
18:45 – 18:50

The shift to long-term success through treatment selection: How has the role of the people with HIV changed?

  • David Malebranche (USA)
  • Marta Boffito (UK)
  • Giovanni Guaraldi (Italy)
18:50 – 19:00

Sustained undetectable viral load: The starting point for treatment success

  • David Malebranche (USA)
  • Marta Boffito (UK)
  • Giovanni Guaraldi (Italy)
19:00 – 19:10

Long-term safety, tolerability and monitoring: What does this really mean?

  • All
19:10 – 19:20
An optimised quality of life for all: The final goal for long-term success 19:20 – 19:30

Audience Q&A

  • David Malebranche (USA)
19:30 – 19:40

Conclusion and thanks

19:40 – 19:45

This promotional meeting is organized by Gilead Sciences Europe Ltd and is intended for healthcare professionals only.

Friday, 20 October

12:15 - 13:45, room POLONEZ

Industry Sponsored Session – Gilead

ART Resistance: A Question of Innovation.
Priorities for avoidance, understanding, and management

Chair: Sorana Segal-Maurer (USA)

Welcome and introduction

Sorana Segal-Maurer (USA)

12:15 - 12:25

Exploring the priorities for ensuring treatment success in diverse populations initiating ART

  • Sorana Segal-Maurer (USA)
  • Antonella Castagna (Italy)
  • Graeme Moyle (UK)

12:25 - 12:40

Stories of real-world success in adults with multi-drug resistant HIV-1 infection

  • Sorana Segal-Maurer (USA)
  • Antonella Castagna (Italy)
  • Graeme Moyle (UK)
12:40 – 13:05

Highlighting the progress made in ensuring virologic success in people with HIV switching ART

  • Sorana Segal-Maurer (USA)
  • Antonella Castagna (Italy)
  • Graeme Moyle (UK)
13:05 – 13:30

Audience Q&A

  • All faculty
13:30 – 13:40

Conclusion and thanks

  • Sorana Segal-Maurer (USA)
13:40 – 13:45

This promotional meeting is organized by Gilead Sciences Europe Ltd and is intended for healthcare professionals only.

17:30 - 18:30, room POLONEZ

Industry Sponsored Session - Janssen

Optimizing HIV outcomes in challenging scenarios in 2023: Is it now plain sailing?

Chair: Alan Winston (UK)

Welcome and Introduction

  • Alan Winston (UK)
17:30 – 17:38

Challenging Scenario 1: Sailing rough seas
A very late diagnosed person with HIV. Case study discussion and Q&A

  • Christoph Stephan (Germany)
17:38 – 18:03

Challenging Scenario 2: In uncharted waters
A highly treatment-experienced young person with HIV. Case study discussion and Q&A

  • Anca Streinu-Cercel (Romania)
18:03 – 18:28

Summary and close

  • Alan Winston (UK)
18:28 – 18:30

Registration

Register now

Programme

Explore it

General information A-Z

All you need to know